MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 286 participants.
Also called NCT01299376
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 286 participants
- Sponsor
- Registry
-
NCT01299376
-
- Other papers using this trial's data
- Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01299376. Randomized; double masking; primary purpose treatment. Start 2011-01-24 (actual); primary completion 2011-11-16 (actual). Results posted on 2017-01-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)
- Condition
- Hypertension
- Intervention (Drug)
- L50/H12.5/A5
- Intervention (Drug)
- L50/H12.5
- Intervention (Drug)
- Placebo to L50/H12.5/A5
- Intervention (Drug)
- Placebo to L50/H12.5
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct01299376- Content hash
1f1e6446361cdba8001c3f7a608c7d70075280b48f1e03db8582e94793cf180e